Review Article
Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
Table 3
The activity and pathophysiological roles of Sirt1 in kidney disease.
| Experimental type | Renal outcome/phenotype | Mechanism | Reference |
| Activity/expression | | | | STZ-diabetic rats | Sirt1 expression↓ | Unclear | Tikoo et al. [40] | STZ-diabetic rats | Sirt1 expression↓ | Unclear | Li et al. [41] | Db/db mice | Sirt1 expression→ | Unclear | Kitada et al. [35] | Calorie-restricted rats | Sirt1 expression↑ | Insulin/IGF-1↓ | Cohen et al. [42] | STZ- and db/db mice | Sirt1 expression↓ | NMN depletion | Hasegawa et al. [43] | Pathophysiological roles | | | | Sirt1+/− mice (PTECs) | Renal aging↑ | Autophagy deficiency | Kume et al. [16] | Sirt1+/− mice (Medullary cells) | UUO-induced renal fibrosis↑ | Decrease of Cox2 expression | He et al. [44] | PTECs-specific Sirt1-TG mice | ROS- and cisplatin-induced PTECs damage↓ | Increase of catalase expression | Hasegawa et al. [45] | Treatment with resveratrol | UUO-induced fibrosis↓ | Suppression of TGF-Smad3 pathway | Li et al. [46] | Sirt1 overexpression (mesangial cells) | ROS-induced apoptosis↓ | Inactivation of p53 | Kume et al. [47] | Sirt1 overexpression (mesangial cells) | TGF-induced apoptosis↓ | Inactivation of Smad7 | Kume et al. [48] | Treatment of SRT1720 (PTECs) | Mitochondrial biogenesis↑, ROS↓ | Activation of PGC-1 | Funk et al. [49] | PTECs-specific Sirt1-TG mice | Diabetes-induced podocyte injury↓ | Epigenetic mechanism | Hasegawa et al. [43] |
|
|
STZ; streptozotocin, PTECs: proximal tubular epithelial cells, ROS: reactive oxygen species, UUO: unilateral ureteral obstruction, TGF: transforming growth factor , IGF-1: insulin-like growth factor 1, Cox2: cyclooxygenase 2, PGC-1: peroxisome proliferator-activated receptor coactivator-1, and NMN; nicotinamide mononucleotide.
|